APOB and hyperlipidemia: Ablation of Ces1g expression in vivo results in both postabsorptive (fasting) and postprandial hyperlipidemia and augmented circulating apoB concentrations due to increased secretion of VLDL (Quiroga et al., 2012a) and chylomicrons (Quiroga et al., 2012b) (Fig. 4).